title: The paradox of respiratory R&D, and why 'inhaled-by-design' heralds a new dawn in asthma and chronic obstructive pulmonary disease treatments.
authors.affiliation: Yeadon Consulting Wickhambreaux, Kent, CT3 1RT, UK. yeadon_m@yahoo.co.uk
authors.forename: Mike
authors.initials: M
authors.lastname: Yeadon
mesh_terms: D000280:Administration, Inhalation; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D015195:Drug Design; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*
chemical_list: D001993:Bronchodilator Agents